Catching “Early” COPD – The Diagnostic Conundrum

References

• Burney PGJ, Patel J, Newson R, Minelli C, Naghavi M. Global and regional trends in COPD mortality, 1990–2010. Eur Respir J. 2015;45(5):1239. doi:10.1183/09031936.00142414
   PubMed Web of Science ®Google Scholar
• Trueman D, Woodcock F, Hancock E. Estimating the Economic Burden of Respiratory Illness in the UK. British Lung Foundation; 2017.
   Google Scholar
• Ford ES, Murphy LB, Khavjou O, Giles WH, Holt JB, Croft JB. Total and state-specific medical and absenteeism costs of COPD among adults aged 18 years in the United States for 2010 and projections through 2020. Chest. 2015;147(1):31–45. doi:10.1378/chest.14-0972
   PubMed Web of Science ®Google Scholar
• Martinez FJ, Rabe KF, Calverley PMA, et al. Determinants of response to roflumilast in severe COPD: pooled analysis of two Randomized Trials. Am J Respir Crit Care Med. 2018;198(10):1268–1278. doi:10.1164/rccm.201712-2493OC
   PubMed Web of Science ®Google Scholar
• Stockley RA, Halpin DMG, Celli BR, Singh D. Chronic obstructive pulmonary disease biomarkers and their interpretation. Am J Respir Crit Care Med. 2018;199(10):1195–1204. doi:10.1164/rccm.201810-1860SO
   Web of Science ®Google Scholar
• Abhishek A, de Pablo P, Cader MZ, Buckley CD, Raza K, Filer A. Diagnostic outcomes associated with ankle synovitis in early inflammatory arthritis: a cohort study. Clin Exp Rheumatol. 2014;32(4):533–538.
   PubMed Web of Science ®Google Scholar
• Lange P, Celli B, Agustí A, et al. Lung-function trajectories leading to chronic obstructive pulmonary disease. N Eng J Med. 2015;373(2):111–122. doi:10.1056/NEJMoa1411532
   PubMed Web of Science ®Google Scholar
• Tantucci C, Modina D. Lung function decline in COPD. Int J Chron Obstruct Pulmon Dis. 2012;7:95–99. doi:10.2147/COPD.S27480
   PubMed Web of Science ®Google Scholar
• Bhatt SP, Soler X, Wang X, et al. Association between functional small airway disease and FEV1 decline in chronic obstructive pulmonary disease. Am J Respir Crit Care Med. 2016;194(2):178–184. doi:10.1164/rccm.201511-2219OC
   PubMed Web of Science ®Google Scholar
• Leem AY, Park B, Kim YS, Chang J, Won S, Jung JY. Longitudinal decline in lung function: a community-based cohort study in Korea. Sci Rep. 2019;9(1):13614. doi:10.1038/s41598-019-49598-9
   PubMedGoogle Scholar
• Chinn S, Jarvis D, Melotti R, et al. Smoking cessation, lung function, and weight gain: a follow-up study. Lancet. 2005;365(9471):1629–1635. doi:10.1016/S0140-6736(05)66511-7
   PubMed Web of Science ®Google Scholar
• Snider GL. Chronic obstructive pulmonary disease: a definition and implications of structural determinants of airflow obstruction for epidemiology. Am Rev Respir Dis. 1989;140(3_pt_2):S3–S8. doi:10.1164/ajrccm/140.3_Pt_2.S3
   PubMedGoogle Scholar
• American Thoracic Society. Definitions, epidemiology, pathophysiology, diagnosis, and staging. Am J Respir Crit Care Med. 1995;152(5pt2):S78–S83. doi:10.1164/ajrccm/152.5_Pt_2.S78
   Google Scholar
• Hogg JC, Macklem PT, Thurlbeck WM. Site and nature of airway obstruction in chronic obstructive lung disease. N Eng J Med. 1968;278(25):1355–1360. doi:10.1056/NEJM196806202782501
   PubMed Web of Science ®Google Scholar
• McDonough JE, Yuan R, Suzuki M, et al. Small-airway obstruction and emphysema in chronic obstructive pulmonary disease. N Eng J Med. 2011;365(17):1567–1575. doi:10.1056/NEJMoa1106955
   PubMed Web of Science ®Google Scholar
• Koo H-K, Vasilescu DM, Booth S, et al. Small airways disease in mild and moderate chronic obstructive pulmonary disease: a cross-sectional study. Lancet Respir Med. 2018;6(8):591–602. doi:10.1016/S2213-2600(18)30196-6
   PubMed Web of Science ®Google Scholar
• Martinez FJ, Han MK, Allinson JP, et al. At the root: defining and halting progression of early chronic obstructive pulmonary disease. Am J Respir Crit Care Med. 2018;197(12):1540–1551. doi:10.1164/rccm.201710-2028PP
   PubMed Web of Science ®Google Scholar
• Vestbo J, Can LP. GOLD stage 0 provide information of prognostic value in chronic obstructive pulmonary disease? Am J Respir Crit Care Med. 2002;166(3):329–332. doi:10.1164/rccm.2112048
   PubMed Web of Science ®Google Scholar
• Brito-Mutunayagam R, Appleton SL, Wilson DH, Ruffin RE, Adams RJ. Global initiative for chronic obstructive lung disease stage 0 is associated with excess FEV1 decline in a representative population sample. CHEST. 2010;138(3):605–613. doi:10.1378/chest.09-2607
   PubMed Web of Science ®Google Scholar
• de Marco R, Accordini S, Cerveri I, et al. Incidence of chronic obstructive pulmonary disease in a cohort of young adults according to the presence of chronic cough and phlegm. Am J Respir Crit Care Med. 2007;175(1):32–39. doi:10.1164/rccm.200603-381OC
   PubMed Web of Science ®Google Scholar
• Allinson JP, Hardy R, Donaldson GC, Shaheen SO, Kuh D, Wedzicha JA. The presence of chronic mucus hypersecretion across adult life in relation to chronic obstructive pulmonary disease development. Am J Respir Crit Care Med. 2016;193(6):662–672. doi:10.1164/rccm.201511-2210OC
   PubMed Web of Science ®Google Scholar
• Vogelmeier C, Martinez FJ, Agusti A, et al. Global strategy for the diagnosis, management and prevention of chronic obstructive pulmonary disease – 2019 Report. Global Initiative for Chronic Obstructive Lung Disease;2018.
   Google Scholar
• Stockley JA, Cooper BG, Stockley RA, Sapey E. Small airways disease: time for a revisit? Int J Chron Obstruct Pulmon Dis. 2017;12:2343–2353. doi:10.2147/COPD.S138540
   PubMed Web of Science ®Google Scholar
• Brashier B, Salvi S. Measuring lung function using sound waves: role of the forced oscillation technique and impulse oscillometry system. Breathe. 2015;11(1):57–65. doi:10.1183/20734735.020514
   Web of Science ®Google Scholar
• Vestbo J, Anderson W, Coxson HO, et al. Evaluation of COPD longitudinally to identify predictive surrogate end-points (ECLIPSE). Eur Respir J. 2008;31(4):869. doi:10.1183/09031936.00111707
   PubMed Web of Science ®Google Scholar
• Lipworth BJ, Jabbal S. What can we learn about COPD from impulse oscillometry? Respir Med. 2018;139:106–109. doi:10.1016/j.rmed.2018.05.004
   PubMed Web of Science ®Google Scholar
• Bhattarai P, Myers S, Chia C, et al. Clinical application of Forced Oscillation Technique (FOT) in early detection of airway changes in smokers. J Clin Med. 2020;9(9):2778. doi:10.3390/jcm9092778
   PubMed Web of Science ®Google Scholar
• Tsushima K, Sone S, Yoshikawa S, et al. Clinical differences in the global initiative for chronic obstructive lung disease stage 0. Respir Med. 2006;100(8):1360–1367. doi:10.1016/j.rmed.2005.11.021
   PubMed Web of Science ®Google Scholar
• Stockley JA, Ismail AM, Hughes SM, Edgar R, Stockley Robert A, Sapey E. Maximal mid-expiratory flow detects early lung disease in α1-antitrypsin deficiency. Eur Respir J. 2017;49(3):1602055. doi:10.1183/13993003.02055-2016
   PubMed Web of Science ®Google Scholar
• Dollfuss RE, Milic-Emili J, Bates DV. Regional ventilation of the lung, studied with boluses of 133xenon. Respir Physiol. 1967;2(2):234–246. doi:10.1016/0034-5687(67)90057-6
   Google Scholar
• Gennimata S-A, Palamidas A, Karakontaki F, et al. Pathophysiology of evolution of small airways disease to overt COPD. COPD. 2010;7(4):269–275. doi:10.3109/15412555.2010.497515
   PubMedGoogle Scholar
• Becklake MR, New A. Index of the intrapulmonary mixture of inspired air. Thorax. 1952;7(1):111. doi:10.1136/thx.7.1.111
   PubMed Web of Science ®Google Scholar
• Horsley AR, Gustafsson PM, Macleod KA, et al. Lung clearance index is a sensitive, repeatable and practical measure of airways disease in adults with cystic fibrosis. Thorax. 2008;63(2):135. doi:10.1136/thx.2007.082628
   PubMed Web of Science ®Google Scholar
• Fuchs SI, Schwerk N, Pittschieler K, et al. Lung clearance index for monitoring early lung disease in alpha-1-antitrypsin deficiency. Respir Med. 2016;116:93–99. doi:10.1016/j.rmed.2016.04.015
   PubMed Web of Science ®Google Scholar
• Crossley D, Renton M, Khan M, Low EV, Turner AM. CT densitometry in emphysema: a systematic review of its clinical utility. Int J Chron Obstruct Pulmon Dis. 2018;13:547–563. doi:10.2147/COPD.S143066
   PubMed Web of Science ®Google Scholar
• Hoffman EA, Lynch DA, Barr RG, van Beek EJR, Parraga G, Investigators I. Pulmonary CT and MRI phenotypes that help explain chronic pulmonary obstruction disease pathophysiology and outcomes. J Magn Reson Imaging. 2016;43(3):544–557. doi:10.1002/jmri.25010
   PubMed Web of Science ®Google Scholar
• Galbán CJ, Han MK, Boes JL, et al. Computed tomography-based biomarker provides unique signature for diagnosis of COPD phenotypes and disease progression. Nat Med. 2012;18(11):1711–1715. doi:10.1038/nm.2971
   PubMed Web of Science ®Google Scholar
• Wijnant SRA, De Roos E, Kavousi M, et al. Trajectory and mortality of preserved ratio impaired spirometry: the Rotterdam Study. Eur Respir J. 2020;55(1):1901217. doi:10.1183/13993003.01217-2019
   PubMed Web of Science ®Google Scholar
• Tai A, Tran H, Roberts M, Clarke N, Wilson J, Robertson CF. The association between childhood asthma and adult chronic obstructive pulmonary disease. Thorax. 2014;69(9):805. doi:10.1136/thoraxjnl-2013-204815
   PubMed Web of Science ®Google Scholar
• Sapey E, Bayley D, Ahmad A, Newbold P, Snell N, Stockley RA. Inter-relationships between inflammatory markers in patients with stable COPD with bronchitis: intra-patient and inter-patient variability. Thorax. 2008;63(6):493–499. doi:10.1136/thx.2007.086751
   PubMed Web of Science ®Google Scholar
• Stone H, McNab G, Wood AM, Stockley RA, Sapey E. Variability of sputum inflammatory mediators in COPD and α1-antitrypsin deficiency. Eur Respir J. 2012;40(3):561. doi:10.1183/09031936.00162811
   PubMed Web of Science ®Google Scholar
• Lomas DA, Silverman EK, Edwards LD, Miller BE, Coxson HO, Tal-Singer R. Evaluation of serum CC-16 as a biomarker for COPD in the ECLIPSE cohort. Thorax. 2008;63(12):1058. doi:10.1136/thx.2008.102574
   PubMed Web of Science ®Google Scholar
• Park HY, Churg A, Wright JL, et al. Club cell protein 16 and disease progression in chronic obstructive pulmonary disease. Am J Respir Crit Care Med. 2013;188(12):1413–1419. doi:10.1164/rccm.201305-0892OC
   PubMed Web of Science ®Google Scholar
• Vestbo J, Edwards LD, Scanlon PD, et al. Changes in forced expiratory volume in 1 second over time in COPD. N Eng J Med. 2011;365(13):1184–1192. doi:10.1056/NEJMoa1105482
   PubMed Web of Science ®Google Scholar
• Jiang R, Burke GL, Enright PL, et al. Inflammatory markers and longitudinal lung function decline in the elderly. Am J Epidemiol. 2008;168(6):602–610. doi:10.1093/aje/kwn174
   PubMed Web of Science ®Google Scholar
• Iwamoto H, Gao J, Pulkkinen V, Toljamo T, Nieminen P, Mazur W. Soluble receptor for advanced glycation end-products and progression of airway disease. BMC Pulm Med. 2014;14(1):68. doi:10.1186/1471-2466-14-68
   PubMedGoogle Scholar
• Cheng DT, Kim DK, Cockayne DA, et al. Systemic soluble receptor for advanced glycation endproducts is a biomarker of emphysema and associated with AGER genetic variants in patients with chronic obstructive pulmonary disease. Am J Respir Crit Care Med. 2013;188(8):948–957. doi:10.1164/rccm.201302-0247OC
   PubMed Web of Science ®Google Scholar
• Lomas DA, Silverman EK, Edwards LD, et al. Serum surfactant protein D is steroid sensitive and associated with exacerbations of COPD. Eur Respir J. 2009;34(1):95. doi:10.1183/09031936.00156508
   PubMed Web of Science ®Google Scholar
• Thomsen M, Ingebrigtsen TS, Marott JL, et al. Inflammatory biomarkers and exacerbations in chronic obstructive pulmonary disease. JAMA. 2013;309(22):2353–2361. doi:10.1001/jama.2013.5732
   PubMed Web of Science ®Google Scholar
• Walter RE, Wilk JB, Larson MG, et al. Systemic inflammation and COPD: the Framingham Heart Study. CHEST. 2008;133(1):19–25. doi:10.1378/chest.07-0058
   PubMed Web of Science ®Google Scholar
• Müllerova H, Maselli DJ, Locantore N, et al. Hospitalized exacerbations of COPD: risk factors and outcomes in the ECLIPSE Cohort. CHEST. 2015;147(4):999–1007. doi:10.1378/chest.14-0655
   PubMed Web of Science ®Google Scholar
• Vedel-Krogh S, Nielsen SF, Lange P, Vestbo J, Nordestgaard BG. Blood eosinophils and exacerbations in chronic obstructive pulmonary disease. the Copenhagen General Population Study. Am J Respir Crit Care Med. 2015;193(9):965–974. doi:10.1164/rccm.201509-1869OC
   Web of Science ®Google Scholar
• Yun JH, Lamb A, Chase R, et al. Blood eosinophil count thresholds and exacerbations in patients with chronic obstructive pulmonary disease. J Allergy Clin Immunol. 2018;141(6):2037–2047.e2010. doi:10.1016/j.jaci.2018.04.010
   PubMed Web of Science ®Google Scholar
• Lee H, Um S-J, Kim YS, et al. Association of the neutrophil-to-lymphocyte ratio with lung function and exacerbations in patients with chronic obstructive pulmonary disease. PLoS One. 2016;11(6):e0156511. doi:10.1371/journal.pone.0156511
   PubMed Web of Science ®Google Scholar
• Xiong W, Xu M, Zhao Y, Wu X, Pudasaini B, Liu J-M. Can we predict the prognosis of COPD with a routine blood test? Int J Chron Obstruct Pulmon Dis. 2017;12:615–625. doi:10.2147/COPD.S124041
   PubMed Web of Science ®Google Scholar
• Jasper A, McIver W, Sapey E, Walton G. Understanding the role of neutrophils in chronic inflammatory airway disease. F1000Research. 2019;8:557. doi:10.12688/f1000research.18411.1
   Google Scholar
• Crisford H, Sapey E, Stockley RA. Proteinase 3; a potential target in chronic obstructive pulmonary disease and other chronic inflammatory diseases. Respir Res. 2018;19(1):180. doi:10.1186/s12931-018-0883-z
   PubMedGoogle Scholar
• Stockley RA. Role of inflammation in respiratory tract infections. Am J Med. 1995;99(6):8S–13S. doi:10.1016/S0002-9343(99)80304-0
   PubMedGoogle Scholar
• Luisetti M, Ma S, Iadarola P, et al. Desmosine as a biomarker of elastin degradation in COPD: current status and future directions. Eur Respir J. 2008;32(5):1146. doi:10.1183/09031936.00174807
   PubMed Web of Science ®Google Scholar
• Carter RI, Mumford RA, Treonze KM, et al. The fibrinogen cleavage product Aα-Val360, a specific marker of neutrophil elastase activity in vivo. Thorax. 2011;66(8):686–691. doi:10.1136/thx.2010.154690
   PubMed Web of Science ®Google Scholar
• Carter RI, Ungurs MJ, Mumford RA, Stockley RA. Aα-Val360: a marker of neutrophil elastase and COPD disease activity. Eur Respir J. 2013;41(1):31–38. doi:10.1183/09031936.00197411
   PubMed Web of Science ®Google Scholar
• Rabinovich RA, Miller BE, Wrobel K, et al. Circulating desmosine levels do not predict emphysema progression but are associated with cardiovascular risk and mortality in COPD. Eur Respir J. 2016;47(5):1365. doi:10.1183/13993003.01824-2015
   PubMed Web of Science ®Google Scholar
• Carter RI, Ungurs MJ, Pillai A, Mumford RA, Stockley RA. The relationship of the fibrinogen cleavage biomarker Aa-Val360 with disease severity and activity in a1-antitrypsin deficiency. CHEST. 2015;148(2):382–388. doi:10.1378/chest.14-0520
   PubMed Web of Science ®Google Scholar
• Burnett D, Hill S, Chamba A, Stockley R. Neutrophils from subjects with chronic obstructive lung disease show enhanced chemotaxis and extracellular proteolysis. Lancet. 1987;330(8567):1043–1046. doi:10.1016/S0140-6736(87)91476-0
   Google Scholar
• Sapey E, Stockley JA, Greenwood H, et al. Behavioral and structural differences in migrating peripheral neutrophils from patients with chronic obstructive pulmonary disease. Am J Respir Crit Care Med. 2011;183(9):1176–1186. doi:10.1164/rccm.201008-1285OC
   PubMed Web of Science ®Google Scholar
• Yip K, Hughes M, Stockley R, Sapey E. S70 Inaccurate neutrophil migration in symptomatic smokers without chronic obstructive pulmonary disease. Thorax. 2019;74(Suppl 2):A46–A46.
   Google Scholar
• Stockley RA. Neutrophils and protease/antiprotease imbalance. Am J Respir Crit Care Med. 1999;160(supplement1):S49–S52. doi:10.1164/ajrccm.160.supplement_1.13
   PubMedGoogle Scholar
• Sapey E, Greenwood H, Walton G, et al. Phosphoinositide 3-kinase inhibition restores neutrophil accuracy in the elderly: toward targeted treatments for immunosenescence. Blood. 2014;123(2):239. doi:10.1182/blood-2013-08-519520
   PubMed Web of Science ®Google Scholar
• Ostuni R, Natoli G, Cassatella MA, Tamassia N. Epigenetic regulation of neutrophil development and function. Semin Immunol. 2016;28(2):83–93. doi:10.1016/j.smim.2016.04.002
   PubMed Web of Science ®Google Scholar
• Piitulainen E, Tornling G, Eriksson S. Effect of age and occupational exposure to airway irritants on lung function in non-smoking individuals with alpha 1-antitrypsin deficiency (PiZZ). Thorax. 1997;52(3):244–248. doi:10.1136/thx.52.3.244
   PubMed Web of Science ®Google Scholar
• Loi ALT, Hoonhorst S, van Aalst C, et al. Proteomic profiling of peripheral blood neutrophils identifies two inflammatory phenotypes in stable COPD patients. Respir Res. 2017;18(1):100. doi:10.1186/s12931-017-0586-x
   PubMedGoogle Scholar
• Hughes MJ, Sapey E, Stockley R. Neutrophil phenotypes in chronic lung disease. Expert Rev Respir Med. 2019;13(10):951–967. doi:10.1080/17476348.2019.1654377
   PubMed Web of Science ®Google Scholar
• Woodruff PG, Barr RG, Bleecker E, et al. Clinical significance of symptoms in smokers with preserved pulmonary function. N Eng J Med. 2016;374(19):1811–1821. doi:10.1056/NEJMoa1505971
   PubMed Web of Science ®Google Scholar
• Regan EA, Lynch DA, Curran-Everett D, et al. Clinical and radiologic disease in smokers with normal spirometry. JAMA Intern Med. 2015;175(9):1539–1549. doi:10.1001/jamainternmed.2015.2735
   PubMed Web of Science ®Google Scholar
• Han MK, Ye W, Kim D-Y, Woodruff P. Pulmonary trials cooperative I. Design of the redefining therapy in early COPD Study. Chronic Obstr Pulm Dis. 2020;7(4):382–389. doi:10.15326/jcopdf.7.4.2020.0157
   PubMedGoogle Scholar